glp 1 approved for type 1 diabetes Ozempic and Other Off-Label Drugs List of approved and pending

Muscle loss, or sarcopenia, is a natural part of ageing, but it can be accelerated by inactivity, inadequate protein intake, and rapid weight loss without appropriate support

Semaglutide Dosing# FDA-approved dosing with established protocols: Ozempic (T2D) : Start 0.25 mg weekly, escalate to 0.5-2 mg over 8-16 weeks Wegovy (obesity) : Start 0.25 mg weekly, escalate through 0.5, 1.0, 1.7, to 2.4 mg maintenance over 16 weeks Rybelsus (oral T2D) : Start 3 mg daily, escalate to 7-14 mg daily over 30-60 days Semaglutide benefits from established guidelines for missed doses, switching between formulations, special populations (renal/hepatic impairment, elderly), and drug interactions

Walking or gentle movement is beneficial

Use breathable bedding materials like cotton or bamboo rather than synthetic fabrics